Back

A selective mineralocorticoid receptor blocker, esaxerenone, attenuates vascular dysfunction and inhibits atherogenesis in apolipoprotein e-deficient mice

28 August 2023 (14:15 - 15:00)
Organised by: Logo
Congress Presentation Part of: Atherosclerosis Atherosclerosis, Cerebrovascular Diseases, Aneurysm, Restenosis ESC Professional Premium Access ESC Congress 2023 European Society of Cardiology

About the speaker

Photo
Doctor Uugantsetseg Munkhjargal

University of Tokushima, Tokushima (Japan)

5 More presentations in this session

Presentation thumbnail
ApoB-specific CD4+ T cells circulate in human blood and formation of a memory population is driven by coronary artery disease and an elevated cardiovascular risk profile
Mrs S. Hansen (Freiburg, DE)
Abstract Slides Video
Presentation thumbnail
Myeloid cannabinoid receptor CB1 deficiency confers atheroprotection in a sex-specific manner
Mr Y. Wang (DE)
Abstract Slides Video
Presentation thumbnail
Olfactory receptor 2 signaling drives experimental abdominal aortic aneurysm formation
Mr P. Schelemei (Cologne, DE)
Abstract Slides Video
Presentation thumbnail
Ischemic stroke is associated with reduced sclerostin expression in human atherosclerotic plaques
Doctor K. Miteva (Geneva, CH)
Abstract Slides Video
Presentation thumbnail
Immune system humanization in dyslipidemic Rag2-KO/IL2rg-KO/CD47-KO/LDL-R KO mice controls atherosclerosis
Professor G. Norata (Milan, IT)
Abstract Slides Video

Access the full session

Session thumbnail
Atherosclerosis

The Event

Event poster

ESC Congress 2023

28 August 2023 14:15 CET
You may be interested in
thumbnail
Congress Session
Novel drugs for cardiovascular diseases
thumbnail
Congress Session
Basic and Translational Late-Breaking Science session
thumbnail
Congress Session
Experimental studies in coronary atherosclerosis disease